Intuitive Surgical, Inc. (ISRG)
Compared to Estimates, Intuitive Surgical (ISRG) Q2 Earnings: A Look at Key Metrics
Although the revenue and EPS for Intuitive Surgical (ISRG) give a sense of how its business performed in the quarter ended June 2026, it might be worth considering how some key metrics compare with Wall Street estimates and the year-ago numbers.
Intuitive Surgical, Inc. (ISRG) Q2 2026 Earnings Call Transcript
Intuitive Surgical, Inc. (ISRG) Q2 2026 Earnings Call Transcript
Intuitive Surgical, Inc. (ISRG) Q2 Earnings and Revenues Top Estimates
Intuitive Surgical, Inc. (ISRG) came out with quarterly earnings of $2.8 per share, beating the Zacks Consensus Estimate of $2.48 per share. This compares to earnings of $2.19 per share a year ago.
Intuitive Surgical Q2 Earnings Call Highlights
Intuitive Surgical NASDAQ: ISRG reported a solid second quarter of 2026, with management pointing to continued global adoption of its da Vinci, da Vinci SP and Ion platforms, even as U.S. procedure growth moderated and China remained challenging.
Can ISRG Defend Its Leadership as Global Competition Intensifies?
ISRG is countering rising global robotic surgery competition with tiered platforms, AI features and a broad ecosystem focused on value over price.
Intuitive Surgical Pre-Q2 Analysis: Buy, Hold or Sell the Stock Now?
Intuitive Surgical heads into Q2 earnings with strong procedure momentum, da Vinci 5 adoption and expectations for another earnings beat despite margin pressures.
Intuitive Surgical Has +35% Upside: A Compelling Buy Story Before July 16
Intuitive Surgical (NASDAQ:ISRG | ISRG Price Prediction) looks compelling ahead of its July 16 earnings report, and the setup rarely gets this clean for a category leader trading well below fair value.
Intuitive Surgical, Inc. (ISRG) Stock Sinks As Market Gains: What You Should Know
Intuitive Surgical, Inc. (ISRG) closed at $406.78 in the latest trading session, marking a -1.16% move from the prior day.
ISRG to Report Q2 Results Next Week: Should You Buy the Stock Now?
ISRG is set to report Q2 results on July 16, with sales and EPS expected to rise, while investors weigh margin pressure against strong adoption of da Vinci 5.
How Big Is the Appendectomy Opportunity for ISRG's Robotic Expansion?
ISRG sees appendectomy as a long-term robotic growth market, but reimbursement limits near-term adoption as clinical evidence continues to build.
Intuitive Surgical, Inc. (ISRG) Rises Higher Than Market: Key Facts
Intuitive Surgical, Inc. (ISRG) concluded the recent trading session at $432.83, signifying a +1.6% move from its prior day's close.
Intuitive Surgical, Inc. (ISRG) is Attracting Investor Attention: Here is What You Should Know
Recently, Zacks.com users have been paying close attention to Intuitive Surgical (ISRG). This makes it worthwhile to examine what the stock has in store.
